Sorin Group is now LivaNova. Follow us here: https://www.linkedin.com/company/livanova/ Sorin Group was a global medical device company and a leader in the treatment of cardiovascular diseases. With 3,900 employees worldwide, the Company developed, manufactured and marketed medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. Headquartered in Milan, Sorin was listed on the Stock Exchanges Milan. Each year, more than one million patients were treated with Sorin devices in more than 100 countries. The life-saving products were in more than 5,000 hospitals worldwide. On February 26, 2015, Sorin Group announced that it will merge with fellow medical devices maker Cyberonics to form a new UK-based company called LivaNova. The merged medical technology companies created a new entity, called LivaNova PLC, which is domiciled in the U.K. Shares of the newly formed company began training on the Nasdaq and the London Stock Exchange on Oct. 19 under the ticker symbol "LIVN." LivaNova is now a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems. At LivaNova, we understand the importance of bringing both clinical and economic value to our customers. We are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. To find out more about LivaNova please visit the official website at: www.livanova.com You will get the latest corporate news, know more about our company culture and, apply to the world-wide career opportunities advertised by our Talent Acquisition team, please follow the LinkedIn LivaNova page here: https://www.linkedin.com/company/livanova/